ARTICLE | Clinical News
Fycompa perampanel regulatory update
May 9, 2016 7:00 AM UTC
FDA approved Fycompa perampanel oral suspension from Eisai as an adjunctive therapy in the treatment of partial-onset seizures, with or without secondarily generalized seizures, and primary generalize...